Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atypical Neuroleptics for Aberrant Behavior in Mental Retardation
NCT00065273Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jul 1998
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone, clozapine, olanzapine in intellectual disability (ID), Developmental delay, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jul 1998; status: completed.
02
Drugs
risperidoneclozapineolanzapine
03
Conditions
intellectual disability (ID)Developmental delay
Beyond the preview
Go deeper on NCT00065273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065273.